Immunome, Inc. <IMNM.O>: Alliance Global Partners Initiates Coverage With Buy Rating; Target Price $32
IMNM•Related News
Priority Technology agrees to go private in USD 8.05-a-share deal led by CEO Priore
PRTH•
Axon Enterprise: On Sept. 18, Co Issued, Sold $1,150 Million Aggregate Principal Amount Of Its 0% Convertible Senior Notes Due 2031
AXON•
Bruker wins over $6 million UC Berkeley order for high-field NMR systems
BRKR•
Baldwin Insurance Group chief accounting officer Lichon returns from leave, ending Daniel’s interim role
BWIN•
Krystal Biotech, Inc. <KRYS.O>: BofA Global Research raises price objective to $400 from $392
KRYS•